Chiara Cilibrasi, PhD
Dr Chiara Cilibrasi is an Associate Editor for the BMC Series and joined in April 2022 after over ten years of research experience. She holds a Master’s degree in Medical Biotechnologies and a PhD in Neuroscience from the University of Milano-Bicocca, where she studied the effect of targeted cell cycle inhibition on glioma stem cells. Following postdoctoral work at the same University, she moved as a Research Fellow to the University of Sussex where she focused on the identification of potential new biomarkers and therapeutic targets in glioblastoma and breast cancer. Chiara actively promotes the publication of open and reproducible research.
Editorial Board List
Executive Editor
Maria Hodges, BMC Series, London, UK
Associate Editor
Chiara Cilibrasi, BMC Series, London, UK
Assistant Editor
Stuart Weir, BMC Series, London, UK
Editorial Board Members
Bárbara Antunes, University of Cambridge, UK
Emmanuelle Belanger, Brown University, USA
Eva Bergstraesser, University Children's Hospital Zurich, Switzerland
Ping-Jen Chen, Kaohsiung Medical University, Taiwan
Hon Wai Benjamin Cheng, Medical Palliative Care Team, Dept. of Medicine & Geriatrics, TMH, Hong Kong
Shao-Yi Cheng, National Taiwan Unviersity, Taiwan R.O.C.
Michael Connolly, University College Dublin, Ireland
Maxine De la Cruz, UT MD Anderson Cancer Center, USA
Ludovica De Panfilis, Azienda USL-IRCCS di Reggio Emilia, Italy
Shelli Feder, Yale University School of Nursing, USA
Anne Finucane, Marie Curie Hospice Edinburgh, UK
Geraldine Foley, Trinity College Dublin, Ireland
Shannon Freeman, University of Northern British Columbia, Canada
Wei Gao, Nanchang University, China
Jan Gärtner, Palliative Care Center Basel, Switzerland
Luca Ghirotto, Azienda USL - IRCCS di Reggio Emilia, Italy
Arunangshu Ghoshal, Tata Memorial Center, India
Marieke Groot, Radboud University Medical Center, Netherlands
Ping Guo, University of Birmingham, UK
Qiaohong Guo, Capital Medical University, China
Ellen Henderson, UCL Institute of Child Health, UK
Debra Howell, University of York, UK
Emma Kirby, University of New South Wales, Australia
Jonathan Koffman, Cicely Saunders Institute, King's College London, UK
Mark Lazenby, University of Connecticut School of Nursing, USA
Thomas LeBlanc, Duke Cancer Institute, USA
Paul Maciejewski, Weill Cornell Medicine, USA
Chetna Malhotra, Duke-NUS Medical School, Singapore
Eva Katharina Masel, Medical University of Vienna, Division of Palliative Medicine, Austria
Natasha Michael, Cabrini Health, Australia, Australia
Jason Mills, Torrens University, Australia
Mitsunori Miyashita, The University of Tokyo, Japan
Carole Parsons, Queen's University Belfast, UK
Natasja Raijmakers, Netherlands Comprehensive Cancer Organisation (IKNL), Netherlands
Eva Schildmann, University Hospital, LMU Munich, Germany
Christian Schulz-Quach, Princess Margaret Hospital, Canada
Shane Sinclair, University of Calgary, Faculty of Medicine, Canada
Kelli Stajduhar, University of Victoria, Canada
Tamara Sussman, McGill University, Canada
Jing-Yu (Benjamin) Tan, Charles Darwin University, Australia
Stefano Terzoni, ASST Santi Paolo e Carlo, San Paolo teaching hospital, Italy
Liesbeth van Vliet, Leiden University, Netherlands
Kirsten Wentlandt, University Health Network, Canada
Anne Wichmann, Radboud University Medical Center, Netherlands
Sriram Yennu, M.D. Anderson Cancer Center, USA
Editorial Advisors
Janet L Abrahm, Brigham and Women's Hospital, USA
Julia Addington-Hall, University of Southampton, UK
Paul Daeninck, University of Manitoba, Canada
Robert Dunlop, King's College London, UK
Robin Fainsinger, University of Alberta, Canada
Albert J Kirshen, University of Toronto, Canada
Barbara A Koenig, Stanford University, USA
Henry McQuay, University of Oxford, UK
Diane Meier, Mount Sinai School of Medicine, USA
Liliana Orellana, Deakin University, Australia
Carla Ripamonti, National Cancer Institute, Italy
